Nous avons mis à jour et harmonisé le Programme pancanadien d’évaluation des anticancéreux, le Programme commun d’évaluation des médicaments et le processus provisoire d’examen des protéines plasmatiques.

This entry was posted on Samedi, janvier 25th, 2020 at 6:26 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.